Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Gronchi, A.; Miah, A.B.; Dei Tos, A.P.; Abecassis, N.; Bajpai, J.; Bauer, S.; Biagini, R.; Bielack, S.; Blay, J.Y.; Bolle, S.; Bonvalot, S.; Boukovinas, I.; Bovee, J.V.M.G.; Boye, K.; Brennan, B.; Brodowicz, T.; Buonadonna, A.; De Álava, E.; Del Muro, X.G.; Dufresne, A.; Eriksson, M.; Fagioli, F.; Fedenko, A.; Ferraresi, V.; Ferrari, A.; Frezza, A.M.; Gasperoni, S.; Gelderblom, H.; Gouin, F.; Grignani, G.; Haas, R.; Hassan, A.B.; Hecker-Nolting, S.; Hindi, N.; Hohenberger, P.; Joensuu, H.; Jones, R.L.; Jungels, C.; Jutte, P.; Kager, L.; Kasper, B.; Kawai, A.; Kopeckova, K.; Krákorová, D.A.; Le Cesne, A.; Le Grange, F.; Legius, E.; Leithner, A.; Lopez-Pousa, A.; Martin-Broto, J.

doi:10.1016/j.annonc.2021.07.006

Cited by 1,115Sarcoma Diagnosis and TreatmentCardiac tumors and thrombiGastrointestinal Tumor Research and Treatment

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Open access

Gronchi, A., Miah, A.B., Dei Tos, A.P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S. +71 more·2021·Annals of Oncology

DOI 10.1016/j.annonc.2021.07.006

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.annonc.2021.07.006

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bone and soft-tissue sarcomas remain difficult to monitor across diagnosis, treatment, and follow-up.
“remain difficult to monitor across diagnosis, treatment, and follow-up [ 1 , 2 ]”
From Signals Alongside Scans: A Genomics-Guided Framework for Liquid Biopsy in Bone and Soft-Tissue Sarcomas (2026) · cites this paper as [2]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

TNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,968 · see citing works
Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children
Drilon, A., Laetsch, T. W., Kummar, S., DuBois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714448 · Cited by 2,824 · see citing works
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
van der Graaf, W. T. A., Blay, J., Chawla, S. P., Kim, D., Bui-Nguyen, B., Casali, P. G., Schöffski, P., Aglietta, M., Staddon, A. P., Beppu, Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60651-5 · Cited by 2,103 · see citing works
Self-citation
Entrectinib in Patients with Advanced or Metastatic NTRK Fusion-Positive Solid Tumours: Integrated Analysis of Three Phase 1-2 Trials
Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., Blakely, C. M., Seto, T., Cho, B. C., Tosi, D., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30691-6 · Cited by 1,790 · see citing works
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
O’Sullivan, B., Davis, A. M., TURCOTTE, R. E., Bell, R. S., Catton, C., Chabot, P., Wunder, J. S., Kandel, R. A., Goddard, K., Sadura, A., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09292-9 · Cited by 1,602 · see citing works
The Treatment of Soft-tissue Sarcomas of the Extremities
Rosenberg, S. A., Tepper, J. E., GLATSTEIN, E. J., Costa, J. C., Baker, A. R., BRENNAM, M., Demoss, E. V., Seipp, C. A., Sindelar, W. F., Sugarbaker, P. H., et al. (1982) · Annals of Surgery · doi:10.1097/00000658-198209000-00009 · Cited by 1,349 · see citing works
Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system
Trojani, M., Contesso, G., Coindre, J., Rouëssé, J., Bui, N. B., de Mascarel, A., Goussot, J. ‐., David, M., Bonichon, F., & Lagarde, C. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330108 · Cited by 1,314 · see citing works
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Judson, I. R., Verweij, J., Gelderblom, H. A. J., Hartmann, J. T., Schöffski, P., Blay, J., Kerst, J. M., Šufliarský, J., Whelan, J. S., Hohenberger, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70063-4 · Cited by 1,185 · see citing works
Self-citation
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.
Pisters, P. W. T., Harrison, L. B., Leung, D. H. Y., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.859 · Cited by 1,005 · see citing works
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
Demetri, G. D., von Mehren, M., Jones, R. L., Hensley, M. L., Schuetze, S. M., Staddon, A. P., Milhem, M. M., ELIAS, A. D., Ganjoo, K. N., Tawbi, H. A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.4734 · Cited by 843 · see citing works
Self-citation
Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002
Maki, R. G., Wathen, J. K., PATEL, S. R., Priebat, D. A., Okuno, S. H., Samuels, B. L., Fanucchi, M. P., Harmon, D. C., Schuetze, S. M., Reinke, D. K., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4117 · Cited by 779 · see citing works
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Schöffski, P., Chawla, S. P., Maki, R. G., Italiano, A., Gelderblom, H. A. J., Choy, E., Grignani, G., de Camargo, V. P., Bauer, S., Rha, S. Y., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01283-0 · Cited by 779 · see citing works
Self-citation
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Gross, A. M., Wolters, P. L., Dombi, E., Baldwin, A. M., Whitcomb, P. O., Fisher, M. J., Weiss, B., Kim, A., Bornhorst, M., Shah, A. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912735 · Cited by 738 · see citing works
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
Penel, N., Bui, B., Bay, J., Cupissol, D., Ray-Coquard, I. L., Piperno-Neumann, S., Kerbrat, P., Fournier, C., Taieb, S., Jiménez, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3146 · Cited by 726 · see citing works
Self-citation
Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial
Frustaci, S., Gherlinzoni, F., Paoli, A. D., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., PIGNATTI, G., Barbieri, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1238 · Cited by 711 · see citing works
Self-citation
ESMO-magnitude of clinical benefit scale version 1.1
Cherny, N. I., Dafni, U., Bogaerts, J., Latino, N. J., Pentheroudakis, G., Douillard, J.-Y., Tabernero, J., Zielinski, C., Piccart, M. J., & de Vries, E. G. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx310 · Cited by 641 · see citing works
Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 637 · see citing works
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Casali, P. G., Blay, J., Abecassis, N., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.09.005 · Cited by 604 · see citing works
Self-citation
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
Woll, P. J., Reichardt, P., Cesne, A. L., Bonvalot, S., Azzarelli, A., Hoekstra, H. J., Leahy, M. G., van Coevorden, F., Verweij, J., Hogendoorn, P. C. W., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70346-7 · Cited by 583 · see citing works
Self-citation
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
Reed, N. S., Mangioni, C., Malmström, H., Scarfone, G., Poveda, A. M., Pecorelli, S., Tateo, S., Franchi, M. P., Jobsen, J. J., Coens, C., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.01.019 · Cited by 534 · see citing works
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Seddon, B. M., Strauss, S. J., Whelan, J. S., Leahy, M. G., Woll, P. J., Cowie, F. J., Rothermundt, C. A., Wood, Z., Benson, C., Ali, N., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30622-8 · Cited by 529 · see citing works
Self-citation
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
Gatta, G., Capocaccia, R., Botta, L., Mallone, S., De Angelis, R., Ardanaz, E., Comber, H., Dimitrova, N., Leinonen, M. K., Siesling, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30445-x · Cited by 516 · see citing works
Self-citation
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients
Alman, B. A., Attia, S., Baumgarten, C., Benson, C., Blay, J., Bonvalot, S., Breuing, J., Cardona, K., Casali, P. G., van Coevorden, F., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.11.013 · Cited by 508 · see citing works
Self-citation
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
Bonvalot, S., Gronchi, A., Pechoux, C. L., Swallow, C. J., Strauß, D., Méeus, P., van Coevorden, F., Stoldt, S., Stoeckle, E., Rutkowski, P. L., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30446-0 · Cited by 497 · see citing works
Self-citation
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
Tap, W. D., Gelderblom, H. A. J., Palmerini, E., Desai, J., Bauer, S., Blay, J., Alcindor, T., Ganjoo, K. N., Martín‐Broto, J., Ryan, C. W., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30764-0 · Cited by 495 · see citing works
Self-citation
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.
Antman, K. H., Crowley, J., Balcerzak, S. P., et al. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1276 · Cited by 485 · see citing works
Sorafenib for Advanced and Refractory Desmoid Tumors
Gounder, M. M., Mahoney, M. R., Tine, B. A. V., Ravi, V., Attia, S., Deshpande, H. A., Gupta, A. A., Milhem, M. M., Conry, R. M., Movva, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805052 · Cited by 464 · see citing works
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Gounder, M. M., Schöffski, P., Jones, R. L., Agulnik, M., Cote, G. M., Villalobos, V. M., Attia, S., Chugh, R. K., Chen, T. W., Jahan, T. M., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30451-4 · Cited by 437 · see citing works
Self-citation
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.
Callegaro, D., Miceli, R., Bonvalot, S., Ferguson, P., Strauss, D., Lévy, A., Griffin, A., Hayes, A., Stacchiotti, S., Péchoux, C. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00010-3 · Cited by 423 · see citing works
Self-citation
Improved survival using specialized multidisciplinary board in sarcoma patients
Blay, J., Soibinet, P., Penel, N., Bompas, E., Duffaud, F., Stoeckle, E., Mir, O., Adam, J., Chevreau, C., Bonvalot, S., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx484 · Cited by 370 · see citing works
Self-citation
Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
The European Reference Network GENTURIS, Frébourg, T., Bajalica‐Lagercrantz, S., Oliveíra, C., Mágenheim, R., & Evans, D. G. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0638-4 · Cited by 344 · see citing works
Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets
Gronchi, A., Miceli, R., Shurell, E., Eilber, F. C., Eilber, F. R., Anaya, D. A., Kattan, M. W., Honoré, C., Lev, D. C., Colombo, C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.3747 · Cited by 336 · see citing works
Self-citation
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma
Issels, R. D., Lindner, L. H., Verweij, J., Wessalowski, R., Reichardt, P., Wust, P., Ghadjar, P., Hohenberger, P., Angele, M. K., Salat, C., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.4996 · Cited by 328 · see citing works
Self-citation
Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study
del Muro, X. G., Pousa, A. L., Maurel, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.6107 · Cited by 307 · see citing works
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
Mir, O., Brodowicz, T., Italiano, A., Wallet, J., Blay, J., Bertucci, F., Chevreau, C., Piperno-Neumann, S., Bompas, E., Salas, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30507-1 · Cited by 280 · see citing works
Self-citation
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group
Trans-Atlantic RPS Working Group (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-016-5336-7 · Cited by 274 · see citing works
Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC–STBSG
Bonvalot, S., Raut, C. P., Pollock, R. E., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2342-2 · Cited by 267 · see citing works
Self-citation
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Gronchi, A., Palmerini, E., Quagliuolo, V., Martín‐Broto, J., Pousa, A. L., Grignani, G., Brunello, A., Blay, J., Tendero, O., Beveridge, R. D., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03289 · Cited by 264 · see citing works
Self-citation
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions
Ray-Coquard, I., Montesco, M. C., Coindre, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr610 · Cited by 262 · see citing works
Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
Park, M. S., PATEL, S. R., Ludwig, J. A., Trent, J. C., Conrad, C. A., Lazar, A. J., Wang, W., Boonsirikamchai, P., Choi, H., Wang, X., et al. (2011) · Cancer · doi:10.1002/cncr.26098 · Cited by 260 · see citing works
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
Lee, C., Ou, W., Mariño‐Enríquez, A., Zhu, M. J., Mayeda, M., Wang, Y., Guo, X., Brunner, A. L., Amant, F. C., French, C. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115528109 · Cited by 258 · see citing works
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
Swallow, C. J., Strauß, D., Bonvalot, S., et al. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-09654-z · Cited by 256 · see citing works
Self-citation
Efficacy of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcoma of the Extremity: 20-year Follow-Up of a Randomized Prospective Trial
Beane, J. D., Yang, J. C., White, D., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3732-4 · Cited by 243 · see citing works
Analysis of Margin Classification Systems for Assessing the Risk of Local Recurrence After Soft Tissue Sarcoma Resection
Gundle, K. R., Kafchinski, L. A., Gupta, S., Griffin, A. M., Dickson, B. C., Chung, P. W. M., Catton, C., O’Sullivan, B., Wunder, J. S., & Ferguson, P. C. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.6941 · Cited by 234 · see citing works
Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas
Gronchi, A., Miceli, R., Colombo, C., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr323 · Cited by 228 · see citing works
Self-citation
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
Pasquali, S., Pizzamiglio, S., Touati, N., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.12.009 · Cited by 213 · see citing works
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.
Cesne, A. L., Antoine, É.-C., Spielmann, M., Chevalier, T. L., Brain, E. G. C., Toussaint, C., Janin, N., Kayitalire, L., Fontaine, F., & Génin, J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1600 · Cited by 206 · see citing works
Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
Florou, V., Rosenberg, A. E., Wieder, E., Komanduri, K. V., Kolonias, D. S., Uduman, M., Castle, J. C., Buell, J. S., Trent, J. C., & Wilky, B. A. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0689-7 · Cited by 184 · see citing works
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
Schöffski, P., Šufliarský, J., Gelderblom, H. A. J., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30116-4 · Cited by 183 · see citing works
Self-citation
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine
Demetri, G. D., Schöffski, P., Grignani, G., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.6605 · Cited by 174 · see citing works
Self-citation
Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma
Hensley, M. L., Wathen, J. K., Maki, R. G., et al. (2013) · Cancer · doi:10.1002/cncr.27942 · Cited by 172 · see citing works
Sunitinib malate in solitary fibrous tumor (SFT)
Stacchiotti, S., Negri, T., Libertini, M., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds143 · Cited by 172 · see citing works
Self-citation
Resection of Pulmonary and Extrapulmonary Sarcomatous Metastases Is Associated With Long-Term Survival
Blackmon, S. H., Shah, N. P., Roth, J. A., Correa, A. M., Vaporciyan, A. A., Rice, D. C., Hofstetter, W. L., Walsh, G. L., Benjamin, R. S., Pollock, R. E., et al. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.04.144 · Cited by 172 · see citing works
Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
Stacchiotti, S., Palassini, E., Sanfilippo, R. G., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr066 · Cited by 159 · see citing works
Self-citation
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) recommendations for pathological examination and reporting
Wardelmann, E., Haas, R. L., Bovée, J. V. M. G., Terrier, P., Lazar, A. J., Messiou, C., Pechoux, C. L., Hartmann, W., Collin, F., Fisher, C., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.09.021 · Cited by 158 · see citing works
Self-citation
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
D’Ambrosio, L., Touati, N., Blay, J., et al. (2020) · Cancer · doi:10.1002/cncr.32795 · Cited by 148 · see citing works
Self-citation
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
Demetri, G. D., Antonescu, C. R., Bjerkehagen, B., Bovée, J. V. M. G., Boye, K., Chacon, M. R., Tos, A. P. D., Desai, J., Fletcher, J. A., Gelderblom, H. A. J., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.2232 · Cited by 148 · see citing works
Self-citation
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial
Martín‐Broto, J., Stacchiotti, S., Pousa, A. L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30676-4 · Cited by 137 · see citing works
Self-citation
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
Constantinidou, A., Jones, R. L., Scurr, M. R., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.08.016 · Cited by 136 · see citing works
Self-citation
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
Gronchi, A., Stacchiotti, S., Verderio, P., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw430 · Cited by 132 · see citing works
Self-citation
ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review
Andritsch, E., Beishon, M., Bielack, S., Bonvalot, S., Casali, P. G., Crul, M., Bolton, R. C. D., Donati, D. M., Douis, H., Haas, R. L., et al. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.12.002 · Cited by 131 · see citing works
Self-citation
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
Sanfilippo, R. G., Jones, R. L., Blay, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0288 · Cited by 131 · see citing works
Self-citation
Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG)
Kasper, B., Gruenwald, V., Reichardt, P., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.001 · Cited by 127 · see citing works
Self-citation
Safety and efficacy of high‐dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study
Skapek, S. X., Anderson, J. R., Hill, D. A., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24457 · Cited by 126 · see citing works
Sorafenib in patients with progressive epithelioid hemangioendothelioma
Chevreau, C., Cesne, A. L., Ray-Coquard, I. L., et al. (2013) · Cancer · doi:10.1002/cncr.28109 · Cited by 124 · see citing works
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
Gelderblom, H. A. J., Cropet, C., Chevreau, C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30143-8 · Cited by 114 · see citing works
Self-citation
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma
Kalbasi, A. K., Kamrava, M. R., Chu, F., Telesca, D., van Dams, R., Yang, Y., Ruan, D., Nelson, S. D., Dry, S., Hernandez, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3524 · Cited by 110 · see citing works
Evaluating the Risks of Electric Uterine Morcellation
Kho, K. A., & NEZHAT, C. H. (2014) · JAMA · doi:10.1001/jama.2014.1093 · Cited by 109 · see citing works
The significance of a marginal excision after preoperative radiation therapy for soft tissue sarcoma of the extremity
Dagan, R., Indelicato, D. J., McGee, L. A., et al. (2011) · Cancer · doi:10.1002/cncr.26489 · Cited by 108 · see citing works
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma
Lansu, J., Bovée, J. V. M. G., Braam, P. M., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.5865 · Cited by 108 · see citing works
Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
Deroose, J. P., Eggermont, A. M. M., van Geel, A. N., Burger, J. W. A., den Bakker, M. A., de Wilt, J. H. W., & Verhoef, C. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.6618 · Cited by 104 · see citing works
What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients
Rothermundt, C. A., Whelan, J. S., Dileo, P., Strauss, S. J., Coleman, J., Briggs, T. W. R., Haile, S. R., & Seddon, B. M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.200 · Cited by 102 · see citing works
Self-citation
Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis
Palassini, E., Frezza, A. M., Mariani, L., et al. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000254 · Cited by 96 · see citing works
Self-citation
Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres
Callegaro, D., Miceli, R., Bonvalot, S., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.09.028 · Cited by 88 · see citing works
Self-citation
Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate – The impact of fibrosarcomatous transformation
Rutkowski, P. L., Klimczak, A., Lugowska, I. A., et al. (2017) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2017.03.011 · Cited by 85 · see citing works
Self-citation
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma
Frezza, A. M., Jones, R. L., Vullo, S. L., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0219 · Cited by 83 · see citing works
Self-citation
Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet
Haas, R. L., Walraven, I., Lecointe‐Artzner, E., et al. (2020) · Cancer · doi:10.1002/cncr.32911 · Cited by 83 · see citing works
Self-citation
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
Stacchiotti, S., Ferrari, S., Redondo, A., Hindi, N., Palmerini, E., Salgado, M. Á. V., Frezza, A. M., Casali, P. G., Gutierrez, A. M., Pousa, A. L., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30319-5 · Cited by 82 · see citing works
Self-citation
Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors
Callegaro, D., Miceli, R., Bonvalot, S., Ferguson, P. C., Strauß, D., van Praag, V. M., Lévy, A., Griffin, A. M., Hayes, A. J., Stacchiotti, S., et al. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.11.008 · Cited by 82 · see citing works
Self-citation
Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential
Ip, P. P. C., & Cheung, A. (2011) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2011.07.003 · Cited by 81 · see citing works
Effectiveness of Regional Hyperthermia With Chemotherapy for High-Risk Retroperitoneal and Abdominal Soft-Tissue Sarcoma After Complete Surgical Resection
Angele, M. K., Albertsmeier, M., Prix, N. J., et al. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000978 · Cited by 79 · see citing works
Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics
Stacchiotti, S., Tortoreto, M., Bozzi, F., Tamborini, E., Morosi, C., Messina, A., Libertini, M., Palassini, E., Cominetti, D., Negri, T., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0776 · Cited by 79 · see citing works
Self-citation
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
Verspoor, F. G. M., Mastboom, M. J. L., Hannink, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51211-y · Cited by 77 · see citing works
Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide
Palassini, E., Ferrari, S., Verderio, P., Paoli, A. D., Martín‐Broto, J., Quagliuolo, V., Comandone, A., Sangalli, C., Palmerini, E., Pousa, A. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.9394 · Cited by 76 · see citing works
Self-citation
Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma
Martín-Liberal, J., Alam, S. M., Constantinidou, A., Fisher, C., Khabra, K., Messiou, C., Olmos, D., Mitchell, S., Al‐Muderis, O., Miah, A. B., et al. (2013) · Sarcoma · doi:10.1155/2013/868973 · Cited by 66 · see citing works
Self-citation
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis
Baldi, G. G., Brahmi, M., Vullo, S. L., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0352 · Cited by 63 · see citing works
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case‐series analysis within the Italian Rare Cancer Network
Stacchiotti, S., Simeone, N., Vullo, S. L., Baldi, G. G., Brunello, A., Vincenzi, B., Palassini, E., Dagrada, G. P., Collini, P., Morosi, C., et al. (2020) · Cancer · doi:10.1002/cncr.33247 · Cited by 55 · see citing works
Self-citation
Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study
Stacchiotti, S., Simeone, N., Vullo, S. L., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.10.024 · Cited by 50 · see citing works
Self-citation
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas
Martín‐Broto, J., Hindi, N., Pousa, A. L., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2019.6584 · Cited by 48 · see citing works
Self-citation
Pazopanib, a promising option for the treatment of aggressive fibromatosis
Szűcs, Z., Messiou, C., Wong, H. H., et al. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000474 · Cited by 47 · see citing works
Self-citation
YWHAE -rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy
Hemming, M. L., Wagner, A. J., Nucci, M. R., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.03.021 · Cited by 45 · see citing works
Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study
Shi, Y., Cai, Q., Jiang, Y., Huang, G., Bi, M., Wang, B., Zhou, Y., Wang, G., Ying, H., Tao, Z., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2819 · Cited by 41 · see citing works
Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard?
Fiore, M., Ford, S., Callegaro, D., et al. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6393-x · Cited by 35 · see citing works
Hormonal Therapy for Aggressive Angiomyxoma
Schwartz, P. E., Hui, P., & MCCARTHY, S. M. (2014) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3182a22019 · Cited by 34 · see citing works
Long-term Outcomes of Oral Vinorelbine in Advanced, Progressive Desmoid Fibromatosis and Influence of CTNNB1 Mutational Status
Mir, O., Honoré, C., Chamseddine, A. N., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1847 · Cited by 25 · see citing works
Self-citation
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Penel, N., Mir, O., Wallet, J., Ray-Coquard, I. L., Cesne, A. L., Italiano, A., Salas, S., Delcambre, C., Bompas, E., Bertucci, F., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.12.001 · Cited by 23 · see citing works
Self-citation
Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis
Nasioudis, D., Mastroyannis, S. A., Latif, N., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.04.001 · Cited by 20 · see citing works
1624MO Weekly nab-paclitaxel for progressive or symptomatic desmoid tumors: A multicenter single arm phase II trial from the Spanish Group for Research on Sarcoma (GEIS)
Martín‐Broto, J., Hindi, N., Redondo, A., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.08.1850 · Cited by 1 · see citing works
Self-citation

Flagged first, then by citations

Sorted by citations

Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Strauss, S. J., Frezza, A. M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., Bonvalot, S., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.08.1995 · Cited by 513 · see citing works
Self-citation
The MDM2-p53 antagonist brigimadlin (BI 907828) in patients with advanced or metastatic solid tumors: results of a phase Ia, first-in-human, dose-escalation study
LoRusso, P., Yamamoto, N., Patel, M. R., Laurie, S. A., Bauer, T. M., Geng, J., Davenport, T., Teufel, M., Li, J., Lahmar, M., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0153 · Cited by 101 · see citing works
Sarcoma care in the era of precision medicine
Wallander, K., Öfverholm, I., Boye, K., Tsagkozis, P., Papakonstantinou, A., Lin, Y., & Haglund de Flon, F. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13717 · Cited by 30 · see citing works
Self-citation
Genotyping of Circulating Free DNA Enables Monitoring of Tumor Dynamics in Synovial Sarcomas
Eisenhardt, A. E., Brugger, Z., Lausch, U., Kiefer, J., Zeller, J., Runkel, A., Schmid, A., Bronsert, P., Wehrle, J., Leithner, A., et al. (2022) · Cancers · doi:10.3390/cancers14092078 · Cited by 18 · see citing works
Self-citation
Improved Quantification of Circulating Tumor <scp>DNA</scp> in Translocation‐Associated Myxoid Liposarcoma by Simultaneous Detection of Breakpoints and Single Nucleotide Variants
Schmid, A., Lausch, U., Runkel, A., Kiefer, J., Pauli, T., Boerries, M., Bogner, B., Eisenhardt, S. U., & Braig, D. (2025) · Cancer Medicine · doi:10.1002/cam4.70704 · Cited by 4 · see citing works
Signals Alongside Scans: A Genomics-Guided Framework for Liquid Biopsy in Bone and Soft-Tissue Sarcomas
Alabid, I., Yousef, A. J., Patni, M. M., Aloti, R. A., Qassim, Z. A.-A. M., Alothman-Agha, A. A., Hamdy, H. A., Noury, F. M., & Abdelfattah, M. T. (2026) · Cells · doi:10.3390/cells15141271

The challenges in finding your home as a multidisciplinary scientist
Wang, S., Marr, L. C., Contreras, L. M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.044 · Cited by 2 · see citing works
[Verification of guideline for gastric cancer treatment based on a questionnaire].
Sekikawa, K., Ohki, S., Kohunato, Y., et al. (2004) · PubMed
Establishing a framework for building multidisciplinary programs
Meguid, C. L., Ryan, C., Edil, B. H., Schulick, R. D., Gajdos, C., Boniface, M., Schefter, T. E., Purcell, W., & McCarter, M. D. (2015) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s96415 · Cited by 32 · see citing works
Organizing a multidisciplinary clinic.
Page, A. J., Cosgrove, D., Elnahal, S. M., et al. (2014) · PubMed · doi:10.3978/j.issn.2304-3865.2014.06.02 · Cited by 22 · see citing works
Clinical Practice Guideline for Soeumin Disease of Sasang Constitutional Medicine: Overview
Lee, E.-J., Koh, B., Kim, D.-R., et al. (2014) · Journal of Sasang Constitutional Medicine · doi:10.7730/jscm.2014.26.1.001 · Cited by 11 · see citing works

Authors: Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., Bolle, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Boye, K., Brennan, B., Brodowicz, T., Buonadonna, A., De Álava, E., Del Muro, X. G., Dufresne, A., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Frezza, A. M., Gasperoni, S., Gelderblom, H., Gouin, F., Grignani, G., Haas, R., Hassan, A. B., Hecker-Nolting, S., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R. L., Jungels, C., Jutte, P., Kager, L., Kasper, B., Kawai, A., Kopeckova, K., Krákorová, D. A., Le Cesne, A., Le Grange, F., Legius, E., Leithner, A., Lopez-Pousa, A., Martin-Broto, J., Merimsky, O., Messiou, C., Mir, O., Montemurro, M., Morland, B., Morosi, C., Palmerini, E., Pantaleo, M. A., Piana, R., Piperno-Neumann, S., Reichardt, P., Rutkowski, P., Safwat, A. A., Sangalli, C., Sbaraglia, M., Scheipl, S., Schöffski, P., Sleijfer, S., Strauss, D., Strauss, S., Sundby Hall, K., Trama, A., Unk, M., van de Sande, M. A. J., van der Graaf, W. T. A., van Houdt, W. J., Frebourg, T., Casali, P. G., & Stacchiotti, S.
Affiliations: University of Milan (IT)
Institute of Cancer Research (GB)
Instituto Português de Oncologia Francisco Gentil (PT)
Homi Bhabha National Institute (IN)
University of Duisburg-Essen (DE)
Instituto Nazionale Tumori Regina Elena (IT)
Olgahospital (DE)
Centre Léon Bérard (FR)
Institut Gustave Roussy (FR)
Institut Curie (FR)
Oslo University Hospital (NO)
Royal Manchester Children's Hospital (GB)
Vienna General Hospital (AT)
Centro di Riferimento Oncologico (IT)
Skåne University Hospital (SE)
Ospedale Regina Margherita (IT)
Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Azienda Ospedaliero-Universitaria Careggi (IT)
Leiden University Medical Center (NL)
Candiolo Cancer Institute (IT)
University of Oxford (GB)
Hospital Universitario Fundación Jiménez Díaz (ES)
University of Mannheim (DE)
University of Helsinki (FI)
Université Libre de Bruxelles (BE)
University Medical Center Groningen (NL)
St Anna Children's Hospital (AT)
National Cancer Center Hospital (JP)
Masaryk Memorial Cancer Institute (CZ)
KU Leuven (BE)
University of Graz (AT)
Tel Aviv Sourasky Medical Center (IL)
Centre Hospitalier Universitaire Vaudois (CH)
Birmingham Women’s and Children’s NHS Foundation Trust (GB)
Istituto Ortopedico Rizzoli (IT)
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
Helios Hospital Berlin-Buch (DE)
The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Aarhus University Hospital (DK)
Azienda Ospedale - Università Padova (IT)
Universitair Ziekenhuis Leuven (BE)
Erasmus MC Cancer Institute (NL)
Royal Marsden Hospital (GB)
University College London Hospitals NHS Foundation Trust (GB)
Institute of Oncology Ljubljana (SI)
ORCID: Gronchi, A.
Miah, A.B.
Bajpai, J.
Bauer, S.
Biagini, R.
Bielack, S.
Blay, J.Y.
Bolle, S.
Bonvalot, S.
Boye, K.
Brennan, B.
Buonadonna, A.
Dufresne, A.
Fagioli, F.
Ferraresi, V.
Ferrari, A.
Frezza, A.M.
Gelderblom, H.
Gouin, F.
Grignani, G.
Haas, R.
Hindi, N.
Hohenberger, P.
Joensuu, H.
Jones, R.L.
Jutte, P.
Kager, L.
Kasper, B.
Kawai, A.
Krákorová, D.A.
Legius, E.
Leithner, A.
Messiou, C.
Mir, O.
Montemurro, M.
Morland, B.
Morosi, C.
Palmerini, E.
Pantaleo, M.A.
Piana, R.
Piperno-Neumann, S.
Reichardt, P.
Rutkowski, P.
Safwat, A.A.
Sangalli, C.
Sbaraglia, M.
Scheipl, S.
Schöffski, P.
Sleijfer, S.
Strauss, D.
Strauss, S.
Trama, A.
Unk, M.
Casali, P.G.
Stacchiotti, S.
Venue: Annals of Oncology
Publisher: Elsevier BV
Published: 2021-11
Volume: 32
Issue: 11
Pages: 1348-1365
ISSN: 0923-7534 (ISSN-L)
DOI: 10.1016/j.annonc.2021.07.006
OpenAlex: W4211038654
Cited by: 1,115
References: 98
Citations by year: 2026: 261 · 2025: 261 · 2024: 216 · 2023: 202 · 2022: 155 · 2021: 17 · 2013: 1
FWCI: 96.45
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
Locations: Annals of Oncology (publishedVersion)
PubMed (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
HAL (submittedVersion, other-oa)
Leiden Repository (Leiden University) (submittedVersion, cc-by)
Lirias (KU Leuven) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
IRIS (submittedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Funders: European Society for Medical Oncology
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
Keywords: soft tissue sarcoma, visceral sarcoma, sarcoma diagnosis, sarcoma treatment, immunohistochemistry, molecular features
MeSH terms: Follow-Up Studies, Humans, Sarcoma, Soft Tissue Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks